Jimmy J. Hwang
Expertise in
16
conditions

Dr. Jimmy J. Hwang

Oncology
1021 Morehead Medical Drive, Building 1, Suite 5300, 
Charlotte, NC 
Accepting New Patients
Offers Telehealth
Referral may be required
Expertise in
16
conditions
1021 Morehead Medical Drive, Building 1, Suite 5300, 
Charlotte, NC 

Overview

Jimmy Hwang is an Oncologist practicing medicine in Charlotte, North Carolina.

Dr. Hwang is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Bone Marrow Aspiration.

Dr. Hwang is board certified in American Board Of Internal Medicine, Medical Oncology. He is actively involved in clinical research, co-authoring 115 peer reviewed articles and participating in 5 clinical trials. Dr. Hwang is currently accepting new patients.

Graduate Institution

University Of Pittsburgh

Residency

University of Pittsburgh, Internal Medicine

Specialties

Oncology

Licenses

Internal Medicine in NC

Board Certifications

American Board Of Internal Medicine, Medical Oncology

Fellowships

University of Pittsburgh, Hematology and Medical Oncology

Hospital Affiliations

Carolinas Medical Center/behav Health

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Atrium Health Levine Cancer Institute (GI/Gastrointestinal Cancer)
1021 Morehead Medical Drive, Building 1, Suite 5300, Charlotte, NC 28204

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 1/2, Open-Label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of an Anti-CTLA-4 Human Monoclonal Antibody (AGEN1884) in Subjects With Advanced or Refractory Cancer and in Subjects Who Have Progressed During Treatment With a PD-1/PD-L1 Inhibitor as Their Most Recent Therapy
A Phase 1/2, Open-Label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of an Anti-CTLA-4 Human Monoclonal Antibody (AGEN1884) in Subjects With Advanced or Refractory Cancer and in Subjects Who Have Progressed During Treatment With a PD-1/PD-L1 Inhibitor as Their Most Recent Therapy
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 1, Nonrandomized, Open-Label Investigation of Subcutaneous Ramucirumab Administration in Participants With Advanced Solid Tumors
A Phase 1, Nonrandomized, Open-Label Investigation of Subcutaneous Ramucirumab Administration in Participants With Advanced Solid Tumors
Enrollment Status: Terminated
Publish Date: February 27, 2023
Intervention Type: Drug
Study Phase: Phase 1
Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
Enrollment Status: Unknown
Publish Date: May 24, 2022
Intervention Type: Drug, Procedure, Radiation
Study Drugs: mFOLFIRINOX, FOLFOX
Study Phase: Phase 2
An Open-Label, Multicenter, Phase 1 Study of Ramucirumab Plus MEDI4736 in Patients With Locally Advanced and Unresectable or Metastatic Gastrointestinal or Thoracic Malignancies
An Open-Label, Multicenter, Phase 1 Study of Ramucirumab Plus MEDI4736 in Patients With Locally Advanced and Unresectable or Metastatic Gastrointestinal or Thoracic Malignancies
Enrollment Status: Completed
Publish Date: January 20, 2021
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1 Dose-Escalation Study of LY2606368 in Combination With Ralimetinib in Patients With Advanced or Metastatic Cancer
A Phase 1 Dose-Escalation Study of LY2606368 in Combination With Ralimetinib in Patients With Advanced or Metastatic Cancer
Enrollment Status: Completed
Publish Date: December 14, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 4 Less Clinical Trials

115 Total Publications

Uncovering PD-L1 among immune cell predictive biomarkers and actionable genetic alterations in anal squamous-cell carcinomas in the era of immunotherapy.
Uncovering PD-L1 among immune cell predictive biomarkers and actionable genetic alterations in anal squamous-cell carcinomas in the era of immunotherapy.
Journal: ESMO open
Published: November 19, 2024
Similar Doctors
Expertise in
29
conditions
Dr. David Rizzieri
Oncology
Expertise in
29
conditions
Dr. David Rizzieri
Oncology

Novant Health Cancer Institute - Elizabeth (Hematology)

125 Queens Road, Suite 610, 
Charlotte, NC 
 (1.0 miles away)
980-302-6600
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Rizzieri is an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Rizzieri is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.

Expertise in
11
conditions
Dr. Manisha Bhutani
Hematology | Oncology
Expertise in
11
conditions
Dr. Manisha Bhutani
Hematology | Oncology

Atrium Health Levine Cancer Institute (Hematology)

1021 Morehead Medical Drive, Building 2, Suite 60201, 
Charlotte, NC 
 (0.2 miles away)
980-442-4363
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Manisha Bhutani is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Bhutani is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bhutani is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine, Hematology. Dr. Bhutani is currently accepting new patients.

Expertise in
7
conditions
Dr. Ifeyinwa Osunkwo
Hematology | Oncology
Expertise in
7
conditions
Dr. Ifeyinwa Osunkwo
Hematology | Oncology

Office

1021 Morehead Medical Dr, 
Charlotte, NC 
 (0.1 miles away)
980-442-2000
Languages Spoken:
English
See accepted insurances

Ifeyinwa Osunkwo is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Osunkwo is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Frequently Asked Questions about Dr. Jimmy J. Hwang

How do I make an appointment with Dr. Jimmy J. Hwang?

You can book an appointment with Dr. Jimmy J. Hwang by calling their office at 980-442-6410. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jimmy J. Hwang a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jimmy J. Hwang is classified as an Elite expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jimmy J. Hwang specialize in?

While Dr. Jimmy J. Hwang is a Oncology, they have specific expertise in Colorectal Cancer, Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Jimmy J. Hwang participate in research or clinical trials?

Yes. Dr. Jimmy J. Hwang has published 115 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Dr. Jimmy J. Hwang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jimmy J. Hwang accept my insurance?

Dr. Jimmy J. Hwang accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 980-442-6410 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hwang's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 22 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile